Results 211 to 220 of about 534,909 (297)

Conditional Survival for Pancreas Graft and Its Associated Factors After Pancreas Transplantation. [PDF]

Ann Gastroenterol Surg
Tomimaru Y, Ito T, Kitamura T, Kenmochi T, Doki Y, Eguchi H.   +5 more
europepmc   +1 more source

Roux‐en‐Y Reconstruction After Esophagectomy for Postoperative Functional Complaints: A Case Series

ANZ Journal of Surgery, EarlyView.
Functional complaints affect half of esophagectomy patients, with no standard treatment. In nine patients, Roux‐en‐Y reconstruction for obstruction, redundant conduit, and weight loss was safely performed, with one major complication and no Grade 4 out of five events. Complete symptom resolution reached 67% at 3 months and 89% at 1 year.
Donika Zogaj, Stefan H. E. M. Clermonts, Frederieke A. Dijkstra, Boudewijn van Etten, Roy J. J. Verhage, Jenneke T. H. Hamminga, Jan Willem Haveman   +6 more
wiley   +1 more source

BEAT-BK: An Adaptive, Randomized Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney-pancreas Transplantation Recipients (BEAT-BK) Study Protocol. [PDF]

Transplant Direct
Gately R, Dymock M, Sabanayagam D, Campbell SB, Craig JC, Dharnidharka V, Francis A, Gleadle JM, Hajek M, Hamilton S, Howell M, Isbel N, Jaure A, Johnson DW, Kanellis J, Keung K, Kim S, Kok J, Kuypers DR, Larkins N, Lim WH, Mainra R, Marsh JA, Mihala G, Nankivell BJ, Ng S, Pilmore H, Scholes-Roberton N, Snelling T, Teixeira-Pinto A, Valks A, Yong K, Hawley C, Wong G.   +33 more
europepmc   +1 more source

Severe Abdominal Aortic Calcification in Pancreaticoduodenectomy: A Vascular Frailty Marker for Selecting Total Pancreatectomy?

ANZ Journal of Surgery, EarlyView.
Severe abdominal aortic calcification on preoperative CT may identify vascular frailty in patients undergoing pancreaticoduodenectomy. Integrated with fistula‐risk scores and frailty assessment, it may inform discussion of standard PD versus planned total pancreatectomy in selected high‐risk patients, while AAC alone is not an indication for TP ...
Mohamed Hajri, Lassad Gharbi, Zied Hadrich, Mohamed Boujemaa   +3 more
wiley   +1 more source

Donor after circulatory death in pancreas transplantation: a scoping review of the literature. [PDF]

Front Transplant
Chassot M, Scheen M, Wassmer CH, Compagnon P, Peloso A, Haidar F.   +5 more
europepmc   +1 more source

Long‐Term Outcomes After Elective Splenectomy for Haematological Disease: A 27‐Year Single‐Centre Study

ANZ Journal of Surgery, EarlyView.
Splenectomy is a safe and effective treatment option in selected patients with haematological disease, despite declining referrals over the last 27 years in the era of targeted therapies. Outcomes are favourable when performed laparoscopically and long‐term follow‐up demonstrates sustained haematologic benefit in surviving patients.
Salil Dutt Barrett, Anthony Downhill, Douglas Greer, William Stevenson, Ian Kerridge, Chris Ward, Matthew Greenwood, Naomi Mackinlay, Luke Coyle, Thomas J. Hugh   +9 more
wiley   +1 more source

Outcomes of pancreas transplantation over two decades: a single-center retrospective cohort study. [PDF]

Ann Surg Treat Res
Shin J, Woo HY, Jo EA, Cho A, Han A, Ahn S, Min S, Ha J.   +7 more
europepmc   +1 more source

Comparative effectiveness of apalutamide‐, abiraterone‐, and enzalutamide‐based doublets in mHSPC

BJU International, EarlyView.
Background and Objective Treatment of metastatic hormone‐sensitive prostate cancer (mHSPC) has evolved from androgen‐deprivation therapy (ADT) alone to combination therapy with androgen receptor pathway inhibitors. Although apalutamide (APA), abiraterone (ABI), and enzalutamide (ENZA) improve outcomes when added to ADT, direct comparative trials ...
Anikó Katalin Valikovics, Dániel Bacsó, Nadeen Samaien, Isabel Pinto Amorim das Virgens, Mahmoud Obeidat, Gergely Bánfi, Boris Hadaschik, Péter Hegyi, Péter Nyirády, Tibor Szarvas   +9 more
wiley   +1 more source

Process Variation in Liver, Kidney, and Pancreas Transplantation: A Multicenter Evaluation From the Consortium for the Holistic Assessment of Risk in Transplant. [PDF]

Transplant Direct
Strauss AT, Caicedo JC, Welsh W, Reed RD, Gordon EJ, Taber D, Ng YH, Ross-Driscoll K, Schold JD, Serper M, Olson A, Harding JL, Adams A, Kirk AD, McElroy LM.   +14 more
europepmc   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

British Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman, Christopher J. Black, Andrea Shin, Daniel Keszthelyi   +3 more
wiley   +1 more source